Researcher profile
Jason R B Dyck
Affiliations
Organizations
Public evidence
10 connected articles
Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada.2024 · Europe PMCMetabolomic Fingerprint of Behavioral Changes in Response to Full-Spectrum Cannabis Extracts.2022 · Europe PMCUnderstanding the Potential Benefits of Cannabidiol for Patients With Schizophrenia: A Narrative Review.2022 · Europe PMCSubstance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study.2021 · PubMed Central Open AccessGeneralized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada.2021 · PubMed Central Open AccessGaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada.2021 · PubMed Central Open AccessMedical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study.2021 · PubMed Central Open AccessOpioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada.2021 · PubMed Central Open AccessCohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014-2017 in Ontario, Canada.2021 · PubMed Central Open AccessChanges in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis.2020 · PubMed Central Open Access
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.